UCB — Drug Prices & Medicare Spending
UCB manufactures 5 drugs tracked by Medicare Part D with total spending of $2.5B.
5
Drugs Tracked
$2.5B
Medicare Spending
$184.27
Avg Cost/Claim
100%
Have Generics
UCB Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Cimzia | Certolizumab Pegol | $3,532.00 | Yes |
| 2 | Vimpat | Lacosamide | $270.00 | Yes |
| 3 | Briviact | Brivaracetam | $399.00 | Yes |
| 4 | Neupro | Rotigotine | $375.00 | Yes |
| 5 | Levetiracetam | Levetiracetam | $21.00 | Yes |
Frequently Asked Questions
UCB manufactures 5 drugs tracked by Medicare Part D, with total annual spending of $2.5B.
Cimzia (Certolizumab Pegol) is the most expensive at $3,532.00 per claim.
5 of 5 UCB drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.